Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.57
-0.62 (-7.57%)
Oct 10, 2025, 11:19 AM EDT - Market open
Wave Life Sciences Revenue
Wave Life Sciences had revenue of $8.70M in the quarter ending June 30, 2025, a decrease of -55.82%. This brings the company's revenue in the last twelve months to $93.95M, down -14.98% year-over-year. In the year 2024, Wave Life Sciences had annual revenue of $108.30M, down -4.42%.
Revenue (ttm)
$93.95M
Revenue Growth
-14.98%
P/S Ratio
13.53
Revenue / Employee
$326,201
Employees
288
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108.30M | -5.00M | -4.42% |
| Dec 31, 2023 | 113.31M | 109.66M | 3,005.10% |
| Dec 31, 2022 | 3.65M | -37.32M | -91.09% |
| Dec 31, 2021 | 40.96M | 20.89M | 104.03% |
| Dec 31, 2020 | 20.08M | 4.09M | 25.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
WVE News
- 22 days ago - Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Wave Life Sciences Ltd. (WVE) Positive RestorAATion-2 Clinical Data Update Conference Transcript - Seeking Alpha
- 5 weeks ago - Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? - Benzinga
- 5 weeks ago - Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 2 months ago - Wave Life Sciences Ltd. (WVE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 - GlobeNewsWire
- 3 months ago - Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months - Seeking Alpha